Alginate-crosslinked chitosan scaffolds as pentoxifylline delivery carriers

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 5, 2010, Pages 1611-1620

  Lin, Hsin Yi ^a   Yeh, Chih Tsung ^a  

^a NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORY DRUGS; CELL ATTACHMENTS; CROSS LINKED CHITOSAN; CROSSLINKED; ENZYMATIC DEGRADATION; IN-VITRO TESTS; INFLAMMATORY REACTION; MACROPHAGE CELLS; PENTOXIFYLLINE; POLYELECTROLYTE COMPLEXES; POROUS SCAFFOLD; QUANTITATIVE STUDY; THERMAL GRAVIMETRIC ANALYSIS; TISSUE-ENGINEERED SCAFFOLDS;

ALGINATE; CHITIN; CHITOSAN; DRUG DELIVERY; SCAFFOLDS;

HYDROGELS;

ALGINIC ACID; CHITOSAN; INTERLEUKIN 6; PENTOXIFYLLINE; POLYELECTROLYTE; SCAFFOLD PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ADHESION; COMPARATIVE STUDY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CROSS LINKING; CYTOKINE PRODUCTION; DRUG RELEASE; ENZYME ACTIVATION; ENZYME DEGRADATION; HYDROPHILICITY; INFRARED SPECTROSCOPY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWELLING; THERMOGRAVIMETRY;

ALGINATES; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; INTERLEUKIN-6; PENTOXIFYLLINE; TISSUE SCAFFOLDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954533586     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4028-2     Document Type: Article

References (50)

1. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature. 2004;428:487-492
2. Ho YC, Mi FL, Sung HW, Kuo PL. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. Int J Pharm. 2009;376:69-75.
3. De la Riva B, Nowak C, Sánchez E, Hernández A, Schulz-Siegmund M, Pec MK, et al. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. Eur J Pharm Biopharm. 2009;73:50-58
4. Holland TA, Bodde EW, Cuijpers VM, Baggett LS, Tabata Y, Mikos AG, et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthr Cartil. 2007;15:187-197
5. Tabata Y. Significance of release technology in tissue engineering. Drug Discov Today. 2005;10:1639-1646
6. Goreish HH, Lewis AL, Rose S, Lloyd AW. The effect of phosphorylcholine-coated materials on the inflammatory response and fibrous capsule formation: in vitro and in vivo observations. J Biomed Mater Res A. 2004;68:1-9.
7. Vicreconti M, Monti L, Muccini R, Bernakiewicz M, Toni A. Even a thin layer of soft tissue may compromise the primary stability of cementless hip stems. Clin Biomech. 2001;16:765-775
8. Chvatal SA, Kim YT, Bratt-Leal AM, Lee H, Bellamkonda RV. Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials. 2008;29:1967-1975
9. Nikkola L, Seppälä J, Harlin A, Ndreu A, Ashammakhi N. Electrospun multifunctional diclofenac sodium releasing nanoscaffold. J Nanosci Nanotechnol. 2006;6:3290-3295 (Pubitemid 44580013)
10. Ju YM, Yu B, West L, Moussy Y, Moussy F. A dexamethasoneloaded PLGA microspheres/collagen scaffold composite for implantable glucose sensors. J Biomed Mater Res A. doi:10.1002/jbm.a.32512.
11. Prabaharan M, Rodriguez-Perez MA, de Saja JA, Mano JF. Preparation and characterization of poly(L-lactic acid)-chitosan hybrid scaffolds with drug release capability. J Biomed Mater Res B Appl Biomater. 2007;81:427-434
12. Ma JY, Jiang WW, Zhou ZT, Li JM, Wang HY. The promoting angiogenesis and anti-inflammation effect of scutellarin on polyglycolic acid scaffold of balb/c mice model. J Asian Nat Prod Res. 2008;10:1147-1153
13. Revell PA. The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface. 2008;5:1263-1278
14. Bessler H, Gilgal R, Djaldetti M, Zahavi I. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol. 1986;40:747-754
15. Costantini TW, Deree J, Loomis W, Putnam JG, Choi S, Baird A, et al. Phosphodiesterase inhibition attenuates alterations to the tight junction proteins occludin and ZO-1 in immunostimulated Caco-2 intestinal monolayers. Life Sci. 2009;84:18-22.
16. Bruynzeel I, Stoof TJ, Willemze R. Pentoxifylline and skin inflammation. Clin Exp Dermatol. 1998;23:168-172
17. Pardakhti A, Alavi SA, Kheshti NM, Eshaghi P, Safaeian L. Effect of slow release pentoxifylline and captopril on delayed pulmonary complications of mustard gas in animal models. Tanaffos. 2009;8:41-49
18. Berman B, Duncan MR. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Investig Dermatol. 1989;92:605-610
19. Berman B, Wietzerbin J, Sanceau J, Merlin G, Duncan MR. Pentoxifylline inhibits certain constitutive and tumor necrosis factor-a induced activities of human normal dermal fibroblasts. J Investig Dermatol. 1992;98:706-712
20. Vukanić ZS, Čolić M, Dimitrijević M. Effect of pentoxifylline on differentiation and maturation of human monocyte-derived dendritic cells in vitro. Int Immunopharmacol. 2007;7:167-174
21. Li Z, Zhang M. Chitosan-alginate as scaffolding material for cartilage tissue engineering. J Biomed Mater Res A. 2005;75: 485-493 (Pubitemid 41463919)
22. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials. 2005;26:3919-3928 (Pubitemid 40038783)
23. Chung TW, Yang J, Akaike T, Cho KY, Nah JW, Kim SI, et al. Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials. 2002;23:2827-2834
24. Ribeiro AJ, Neufeld RJ, Arnaud P, Chaumeil JC. Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres. Int J Pharm. 1999;187:115-123
25. Shu XZ, Zhu KJ. The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: the preparation method effect. Eur J Pharm Biopharm. 2002;53:193-201.
26. Olmez SS, Korkusuz P, Bilgili H, Senel S. Chitosan and alginate scaffolds for bone tissue regeneration. Pharmazie. 2007;62: 423-431
27. Vandenberg GW, Drolet C, Scott SL, de la Noüe J. Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation. J Control Release. 2001;77:297-307.
28. Takeuchi H, Yasuji T, Yamamoto H, Kawashima Y. Spray-dried lactose composite particles containing an ion complex of alginate- chitosan for designing a dry-coated tablet having a timecontrolled releasing function. Pharm Res. 2000;17:94-99
29. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release. 2006;114:1-14.
30. Zimmermann U, Klöck G, Federlin K, Hannig K, Kowalski M, Bretzel RG, et al. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis. 1992;13: 269-274
31. Mumper RJ, Hoffman AS, Puolakkainen PA, Bouchard LS, Gombotz WR. Calcium-alginate beads for the oral delivery of transforming growth factor-b1 (TGF-b1): stabilization of TGF-b1 by the addition of polyacrylic acid within acid-treated beads. J Control Release. 1994;30:241-251
32. Chandy T, Sharma CP. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials. 1993;14:939-944
33. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998;15:1326-1331
34. Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001;51:81-96.
35. Machado CB, Ventura JM, Lemos AF, Ferreira JM, Leite MF, Goes AM. 3D chitosan-gelatin-chondroitin porous scaffold improves osteogenic differentiation of mesenchymal stem cells. Biomed Mater. 2007;2:124-131
36. Richardson SM, Hughes M, Hunt JA, Freemont AJ, Hoyland JA. Human mesenchymal stem cell differentiation to NP-like cells in chitosan- glycerophosphate hydrogels. Biomaterials. 2008;29: 85-93.
37. Hou LT, Liu CM, Liu BY, Chang PC, Chen MH, Ho MH, et al. Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2-atelocollagen composite scaffolds. J Periodontol. 2007;78:335-343
38. Kerbel RS. Growth factors as mediators of malignant tumor progression. Cancer Metastasis Rev. 1993;12:215-217
39. Aiba S. Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated chitosans. Int J Biol Macromol. 1992;14:225-228
40. Lin H, Bumgardner JD. In vitro biocorrosion of Co-Cr-Mo implant alloy by macrophage cells. J Orthop Res. 2004;22:1231-1236 (Pubitemid 39317912)
41. Ribeiro AJ, Silva C, Ferreira D, Veiga F. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur J Pharm Sci. 2005;25:31-40. (Pubitemid 40602193)
42. Wendlandt WW. Thermal analysis. 3rd ed. New York: Wiley; 1986.
43. Takahashi T, Takayama K, Machida Y, Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm. 1990;61:35-41.
44. Lawrie G, Keen I, Drew B, Chandler-Temple A, Rintoul L, Fredericks P, et al. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules. 2007;8:2533-2541
45. Madihally SV, Matthew HW. Porous chitosan scaffolds for tissue engineering. Biomaterials. 1999;20:1133-1142
46. Höltje JV. Lysozyme substrates. EXS. 1996;75:105-110
47. Kuroki R, Ito Y, Kato Y, Imoto T. A covalent enzyme-substrate adduct in a mutant hen egg white lysozyme (D52E). J Biol Chem. 1997;272:19976-19981
48. Kirby AJ. The lysozyme mechanism sorted-after 50 years. Nat Struct Biol. 2001;8:737-739
49. Hamdan M, Blanco L, Khraisat A, Tresguerres IF. Influence of titanium surface charge on fibroblast adhesion. Clin Implant Dent Relat Res. 2006;8:32-38
50. Kofuji K, Akamine H, Qian CJ, Watanabe K, Togan Y, Nishimura M, et al. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation. Int J Pharm. 2004; 272:65-78.